Crohn’s Disease is a type of Inflammatory Bowel Disease (IBD) that affects any part of the gastrointestinal tract from mouth to anus. Increasing demand for biologics for treating or preventing bowel disorders such as ulcerative collates and crohn’s disease is driving the overall growth of the crohn’s disease market. High cost of treatment is the major factor that is restricting the market growth. Crohn’s Disease Market is Expected to Grow at a CAGR of 3% from 2016 to 2022.
Major factors leading to the growth of the market includes higher preference for symptomatic therapeutic, better treatment of inflammatory bowel diseases, arrival of enhanced drugs and healthier investments in R&D programs. High cost of treatment and lack of early diagnosis techniques are the major factor restricting the market growth.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2344
Global Crohn’s Disease Market – Key Players
Key players profiled in the report are
- Allergan, Inc.
- AbbVie Inc.
- Takeda Pharmaceutical Company Limited
- Bayer AG
- UCB S.A.
- Perrigo Company plc.
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Ferring B.V.
Crohn’s Disease Market – Competitive Analysis
The Global Crohn’s Disease Market is a fragmented market with many players. Product development strategy has been curtailed by the excellent efficiency and efficacy of drugs. However, the rise of drug resistance has opened doors for new drug development and is an opportunity for a new market leader. The rise of spurious and counterfeit medicines has reduced the total market revenues and at the same time displaced standard drugs off the market.
March 27, 2018 – Researchers at the University of Alberta (Canada), published the study of the potential biomarkers they have developed to help reduce the suffering of Crohn’s disease patients. These scientists used high performance liquid chromatography with mass spectrometry and created a profile of potential biomarkers.
April 03, 2018 – TiGenix NV (Belgium), a global cell therapy company and Takeda Pharmaceutical (Japan), the largest global pharmaceutical company, together announced approval from the EC (European Commission) for the treatment Alofisel (darvadstrocel) they have developed to treat the complex perianal fistulae in adult patients with non-active (mildly active) luminal Crohn’s disease. This is the first allogeneic stem cell therapy (originating from donor stem cells) to receive central marketing authorisation (MA) approval in Europe.
Crohn’s Disease Market – Segmentation
Global Crohn’s Disease Market is segmented in to 3 Key dynamics for an easy grasp and enhanced understanding.
By Procedures: Comprises – Colonoscopy, Flexible Sigmoidoscopy, Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), Capsule Endoscopy, and Small Bowel Imaging & Double-Balloon Endoscopy among others.
By Drug Types: Anti-Diarrheal, Antibiotics, Immune System Suppressors, Anti-Inflammatory Drugs Pain Relievers among others.
By Regions: North America, Europe, APAC and Rest of the World.
Global Crohn’s Disease Market – Regional Analysis
North America accounts for the largest market share of the global Crohn’s Disease Market followed by the Europe & Asia Pacific regions. The North America market is growing due to the largest contribution from the significantly growing market of the US.
Browse Complete 85 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/crohns-disease-market-2344
On the other hand, growth of the world’s second largest market for Crohn’s Disease, (Europe) is driven by the higher per capita income and strong healthcare penetration in the region.
While Asia Pacific market for the Crohn’s Disease is expected to perceive an exponential growth. The market growth will be led by China and India owing to the huge population and the low cost of Crohn’s drugs.
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar